Cytokeratin expression of benign and malignant epithelial thyroid tumours. An immunohistochemical study of 154 neoplasias using 8 different monoclonal anti-cytokeratin antibodies;Zytokeratinexpression benigner und maligner epithelialer Schilddrusentumoren. Eine immunhistologische Untersuchung an 154 Neoplasien unter Einsatz von 8 verschiedenen monoklonalen Zytokeratinantikorpern

Pathologe

Volumn 17, Issue 6, 1996, Pages 425-432

  Schroder S ^b   Wodzynski, A ^a,b   Padberg, B ^a,b  

^a IPM   (Germany)

^b NONE

Author keywords

cytokeratin; immunohistology; intermediate filaments; thyroid gland; tumors

Indexed keywords

CYTOKERATIN;

ANAPLASTIC CARCINOMA; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ANTIBODIES, MONOCLONAL; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030474578     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050181     Document Type: Article

References (38)

1. Berezowski K, Stastny JF, Kornstein MJ (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9: 426-429
2. Bronner MP, LiVolsi VA (1991) Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 4: 637-643
3. Carney JA, Ryan J, Goellner JR (1987) Hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol 11: 583-591
4. Carney JA (1989) Hyalinizing trabecular adenoma (letter). Am J Surg Pathol 13: 809-811
5. Cerasoli S, Tabarri B, Farabegoli P, Vascotto L, Lanzanova G, Pasquinelli GA, Tison V (1992) Hyalinizing trabecular adenoma of the thyroid. Report of two cases with cytologic, immunohistochemical and ultrastructural studies. Tumori 78: 274-279
6. Dalal P, Shousha S (1995) Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions. Mod Pathol 8: 413-416
7. Dockhorn-Dworniczak B, Franke WW, Schröder S, Czernobilsky B, Gould VE, Böcker W (1987) Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas. Differentiation 35: 53-71
8. Droese M, Altmannsberger M, Dralle H (1984) Verteilung der Intermediärfilamente in Schilddrüsencarcinomen. Verh Dtsch Ges Pathol 68: 498
9. Eckert F, Schmid U, Gloor F, Hedinger C (1986) Evidence of vascular differentiation in anaplastic tumours of the thyroid - an immunohistological study. Virchows Arch [A] 410: 203-215
10. Evans HL (1987) Encapsulated papillary neoplasms of the thyroid. A study of 14 cases followed for a minimum of 10 years. Am J Surg Pathol 11: 592-597
11. Franke WW, Winter S, von Overbeck J, Gudat F, Heitz PU, Stähli C (1987) Identification of the conserved, conforma-tion-dependent cytokeratin epitope recognized by monoclonal antibody (lu-5). Virchows Arch [A] 411: 137-147
12. Gatalica Z, Kovatich A, Miettinen M (1995) Consistent expression of cytokeratin 7 in papillary renal cell carcinoma. An immunohistochemical study in formalin-fixed, paraffin-embedded tissues. J Urol Pathol 3: 205-211
13. Guerrieri C, Frånlund B, Boeryd B (1995) Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. Mod Pathol 8: 573-576
14. Habib K, Auriol M, Sarfati E, de Roquancourt A, Wann AR, Brocheriou C, Chomette G (1993) Carcinomes indifférenciés du corps thyroïde. A propos de dix cas. Arch Anat Cytol Pathol 41: 129-139
15. Harnden P, Allam A, Joyce AD, Patel A, Selby P, Southgate J (1995) Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 27: 169-174
16. Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. International histological classification of tumours. 2nd edn. Springer, Berlin Heidelberg New York
17. Henzen-Logmans SC, Mullink H, Ramaekers PCS, Tadema T, Meijer CJLM (1987) Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch [A] 410: 347-354
18. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
19. Katoh R, Jasani B, Williams ED (1989) Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrastructural studies. Histopathology 15: 211-224
20. Miettinen M (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8: 384-388
21. Miettinen M, Franssila K, Lehto K, Lehto VP, Virtanen I (1984) Expression of intermediate filaments in thyroid gland and in thyroid tumours. J Submicrosc Cytol 16: 181
22. Mills SE, Gaffey MJ, Watts JC, Swanson PE, Wick MR, LiVolsi VA, Nappi O, Weiss LM (1994) Angiomatoid carcinoma and "angiosarcoma" of the thyroid gland. A spectrum of endothelial differentiation. Am J Clin Pathol 102: 322-330
23. Moll R (1987) Epithelial tumor markers: cytokeratins and tissue polypeptide antigen (TPA). In: Seifert G (ed) Morpho-logical tumor markers, current topics in pathology, vol 77: Springer. Berlin Heidelberg New York, pp 71-101
24. Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140: 427-447
25. Permanetter W, Nathrath WBJ. Löhrs U (1982) Immunohistochemical analysis of thyroglobulin and keratin in benign and malignant thyroid tumours. Virchows Arch [A] 398: 221-228
26. Raphael SJ, Apel RL,1 Asa SL (1995) Detection of high-molecular-weight cytokeratins in neoplastic and non-neoplastic thyroid tumors using microware antigen retrieval. Mod Pathol 8: 870-872
27. Raphael SJ, McKeown-Eyssen G, Asa SL (1994) High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod Pathol 7: 295-300
28. Rosai J, Carcangiu ML, DeLellis RA (1992) Tumor of the thyroid gland. Atlas of tumor pathology, 3 rd. series, fascicle 5. Armed Forces Institute of Pathology. Washington D. C.
29. Schröder S, Böcker W (1986) Clear-cell carcinomas of the thyroid gland: a clinicopathological study of 13 cases. Histopathology 10: 75-89
30. Schröder S, Dockhorn-Dworniczak B, Kastendieck H, Böcker W, Franke WW (1986) Intermediate-filament expression in thyroid gland carcinomas. Virchows Arch [A] 409: 751-766
31. Takei H, Iino Y, Horiguchi J, Kanoh T, Takao Y, Oyama T, Morishita Y (1995) Immunohistochemical analysis of cytokeratin # 8 as a prognostic factor in invasive breast carcinoma. Anticancer Res 15: 1101-1106
32. Tötsch M, Dobler G, Fiechtinger H, Sandbichler P, Ladurner D, Schmid KW (1990) Malignant hemangioendothelioma of the thyroid. Its immunohistochemical discrimination from undifferentiated thyroid carcinoma. Am J Surg Pathol 14: 69-74
33. Uchida H, Nakayama I, Noguchi S (1989) An immunohistochemical study of cytokeratin and vimentin in benign and malignant thyroid lesions. Acta Pathol Jpn 39: 169-175
34. Viale G, dellOrto P, Coggi G, Gambacorta M (1989) Coexpression of cytokeratins and vimentin in normal and diseased thyroid glands. Lack of diagnostic utility of vimentin immunostaining. Am J Surg Pathol 13: 1034-1040
35. Vollenweider I, Hedinger C Saremaslani P, Pfaltz M (1989) Malignant haemangioendothelioma of the thyroid, immunohistochemical evidence of heterogeneity. Pathol Res Pract 184: 376-381
36. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3: 99-107
37. Wauters CCAP, Smedts F, Gerrits LGM, Bosman FT, Ramaekers PCS (1995) Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 26: 852-855
38. Yagi Y, Yagi S, Saku T (1985) The localization of cytoskeletal proteins and thyroglobulin in thyroid microcarcinoma in comparison with clinically manifested thyroid carcinoma. Cancer 56: 1967-1971